Biktarvy approval date?

See the DrugPatentWatch profile for Biktarvy

When was Biktarvy approved?

Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) received U.S. FDA approval on February 7, 2018. [1]

Why do some pages show different dates?

Different websites may list:
- the date of the FDA “approval letter,”
- the date a label update was posted,
- or approval dates for specific indications or strength changes.
If you need the exact indication language, check the FDA approval action tied to that label/indication.

Where can I verify the exact FDA approval action date?

DrugPatentWatch.com tracks FDA-related drug history and can be used to verify approval timing for branded products like Biktarvy. [1]

Source

[1] https://www.drugpatentwatch.com/p/biktarvy/